Arrhythmogenic cardiomyopathy: Identification of desmosomal gene variations and desmosomal protein expression in variation carriers

Wang,Li; Liu,Shenghua; Zhang,Hongliang; Hu,Shengshou; Wei,Yingjie

doi:10.3892/etm.2018.5694

Arrhythmogenic cardiomyopathy: Identification of desmosomal gene variations and desmosomal protein expression in variation carriers

Authors:
- Li Wang
- Shenghua Liu
- Hongliang Zhang
- Shengshou Hu
- Yingjie Wei
View Affiliations

Affiliations: State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China
Published online on: January 4, 2018 https://doi.org/10.3892/etm.2018.5694
Pages: 2255-2262
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Arrhythmogenic cardiomyopathy (AC) is an inherited disorder that is predominantly present in the right ventricular myocardium. Mutations in the genes encoding the desmosomal protein are thought to underlie the pathogenesis of AC. Since AC is genetically heterogeneous and phenotypically diverse, modifier genes and environmental factors have an important role in disease expression. The aim of the present study was to identify AC‑associated desmosomal gene variations, and examine the expression levels of intercalated disc proteins in AC patients who carry the variations (DSG2 p.Leu797Gln, PKP2 p.Ser249Thr and p.E808fsX30). The results of the present investigation provided information on the search for modifier genes and desmosomal gene mutations, and improved our understanding of the mechanism underlying these AC mutations. Genetic screening of five desmosomal genes (DSG2, DSC2, JUP, PKP2, and DSP) in 23 patients with AC who underwent heart transplantation was performed and the expression levels and localizations of intercalated disc proteins were assessed using western blotting and immunohistochemistry, respectively. The results enabled the identification of three desmosomal gene variations (DSG2 L797Q, PKP2 S249T, and E808fsX30), two of which are reported for the first time. DSG2 L797Q was identified in one patient. The protein expression levels of DSG2 in the L797Q carrier were unchanged compared with the healthy controls, and the expression levels of the other proteins (JUP and Cx43) in the intercalated disc were also similar between the healthy controls, the variation carrier and the case controls. Two variations (S249T and E808fsX30) in PKP2 were identified in one patient, the protein expression levels of PKP2 in this patient were significantly decreased, and the expression levels of the other proteins in the intercalated disc was also decreased. The data suggest that there may be modifier genes and other AC‑associated mutations requiring identification, in order to further our understanding of the disease mechanism induced by these mutations.

View Figures

View References

1	Awad MM, Calkins H and Judge DP: Mechanisms of disease: Molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med. 5:258–267. 2008. View Article : Google Scholar : PubMed/NCBI
2	Dalal D, Nasir K, Bomma C, Prakasa K, Tandri H, Piccini J, Roguin A, Tichnell C, James C, Russell SD, et al: Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation. 112:3823–3832. 2005. View Article : Google Scholar : PubMed/NCBI
3	Fressart V, Duthoit G, Donal E, Probst V, Deharo JC, Chevalier P, Klug D, Dubourg O, Delacretaz E, Cosnay P, et al: Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Spectrum of mutations and clinical impact in practice. Europace. 12:861–868. 2010. View Article : Google Scholar : PubMed/NCBI
4	Saffitz JE: Arrhythmogenic cardiomyopathy and abnormalities of cell-to-cell coupling. Heart Rhythm. 6(8 Suppl): S62–S65. 2009. View Article : Google Scholar : PubMed/NCBI
5	Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C, Bauce B, Carraro G, Thiene G, Towbin JA, et al: Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 65:366–373. 2005. View Article : Google Scholar : PubMed/NCBI
6	Merner ND, Hodgkinson KA, Haywood AF, Connors S, French VM, Drenckhahn JD, Kupprion C, Ramadanova K, Thierfelder L, McKenna W, et al: Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet. 82:809–821. 2008. View Article : Google Scholar : PubMed/NCBI
7	Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, Larderet G, Brahmbhatt B, Brown K, Bauce B, et al: Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (arvd2). Hum Mol Genet. 10:189–194. 2001. View Article : Google Scholar : PubMed/NCBI
8	van Tintelen JP, Van Gelder IC, Asimaki A, Suurmeijer AJ, Wiesfeld AC, Jongbloed JD, van den Wijngaard A, Kuks JB, van Spaendonck-Zwarts KY, Notermans N, et al: Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the des gene. Heart Rhythm. 6:1574–1583. 2009. View Article : Google Scholar : PubMed/NCBI
9	Taylor M, Graw S, Sinagra G, Barnes C, Slavov D, Brun F, Pinamonti B, Salcedo EE, Sauer W, Pyxaras S, et al: Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation. 124:876–885. 2011. View Article : Google Scholar : PubMed/NCBI
10	Bauce B, Nava A, Beffagna G, Basso C, Lorenzon A, Smaniotto G, De Bortoli M, Rigato I, Mazzotti E, Steriotis A, et al: Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 7:22–29. 2010. View Article : Google Scholar : PubMed/NCBI
11	Lorenzon A, Beffagna G, Bauce B, De Bortoli M, Li Mura IE, Calore M, Dazzo E, Basso C, Nava A, Thiene G and Rampazzo A: Desmin mutations and arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 111:400–405. 2013. View Article : Google Scholar : PubMed/NCBI
12	Rasmussen TB, Hansen J, Nissen PH, Palmfeldt J, Dalager S, Jensen UB, Kim WY, Heickendorff L, Mølgaard H, Jensen HK, et al: Protein expression studies of desmoplakin mutations in cardiomyopathy patients reveal different molecular disease mechanisms. Clin Genet. 84:20–30. 2013. View Article : Google Scholar : PubMed/NCBI
13	Rasmussen TB, Palmfeldt J, Nissen PH, Magnoni R, Dalager S, Jensen UB, Kim WY, Heickendorff L, Mølgaard H, Jensen HK, et al: Mutated desmoglein-2 proteins are incorporated into desmosomes and exhibit dominant-negative effects in arrhythmogenic right ventricular cardiomyopathy. Hum Mutat. 34:697–705. 2013. View Article : Google Scholar : PubMed/NCBI
14	Liang WC, Tian X, Yuo CY, Chen WZ, Kan TM, Su YN, Nishino I, Wong LC and Jong YJ: Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan. PLoS One. 12:e01705172017. View Article : Google Scholar : PubMed/NCBI
15	Jiang B, Chen Y, Xu B, Hong N, Liu R, Qi M and Shen L: Identification of a novel missense mutation of MIP in a Chinese family with congenital cataracts by target region capture sequencing. Sci Rep. 7:401292017. View Article : Google Scholar : PubMed/NCBI
16	Miyanaga A, Masuda M, Tsuta K, Kawasaki K, Nakamura Y, Sakuma T, Asamura H, Gemma A and Yamada T: Hippo pathway gene mutations in malignant mesothelioma: Revealed by RNA and targeted exon sequencing. J Thorac Oncol. 10:844–851. 2015. View Article : Google Scholar : PubMed/NCBI
17	Kinnear C, Glanzmann B, Banda E, Schlechter N, Durrheim G, Neethling A, Nel E, Schoeman M, Johnson G and van Helden PD: Exome sequencing identifies a novel TTC37 mutation in the first reported case of Trichohepatoenteric syndrome (THE-S) in South Africa. BMC Med Genet. 18:262017. View Article : Google Scholar : PubMed/NCBI
18	Frank R, Fontaine G, Vedel J, Mialet G, Sol C, Guiraudon G and Grosgogeat Y: Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia. Arch Mal Coeur Vaiss. 71:963–972. 1978.(In French). PubMed/NCBI
19	Basso C, Corrado D, Marcus FI, Nava A and Thiene G: Arrhythmogenic right ventricular cardiomyopathy. Lancet. 373:1289–1300. 2009. View Article : Google Scholar : PubMed/NCBI
20	Campuzano O, Alcalde M, Allegue C, Iglesias A, García-Pavía P, Partemi S, Oliva A, Pascali VL, Berne P, Sarquella-Brugada G, et al: Genetics of arrhythmogenic right ventricular cardiomyopathy. J Med Genet. 50:280–289. 2013. View Article : Google Scholar : PubMed/NCBI
21	van der Zwaag PA, Jongbloed JD, van den Berg MP, van der Smagt JJ, Jongbloed R, Bikker H, Hofstra RM and van Tintelen JP: A genetic variants database for arrhythmogenic right ventricular dysplasia/cardiomyopathy. Hum Mutat. 30:1278–1283. 2009. View Article : Google Scholar : PubMed/NCBI
22	Kapplinger JD, Landstrom AP, Salisbury BA, Callis TE, Pollevick GD, Tester DJ, Cox MG, Bhuiyan Z, Bikker H, Wiesfeld AC, et al: Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. J Am Coll Cardiol. 57:2317–2327. 2011. View Article : Google Scholar : PubMed/NCBI
23	Murray B: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): A review of molecular and clinical literature. J Genet Couns. 21:494–504. 2012. View Article : Google Scholar : PubMed/NCBI
24	Towbin JA: Arrhythmogenic right ventricular cardiomyopathy: A paradigm of overlapping disorders. Ann Noninvasive Electrocardiol. 13:325–326. 2008. View Article : Google Scholar : PubMed/NCBI
25	Sen-Chowdhry S, Syrris P, Pantazis A, Quarta G, McKenna WJ and Chambers JC: Mutational heterogeneity, modifier genes and environmental influences contribute to phenotypic diversity of arrhythmogenic cardiomyopathy. Circ Cardiovasc Genet. 3:323–330. 2010. View Article : Google Scholar : PubMed/NCBI
26	Calkins H: Arrhythmogenic right ventricular dysplasia. Curr Probl Cardiol. 38:103–123. 2013. View Article : Google Scholar : PubMed/NCBI
27	Gerull B, Heuser A, Wichter T, Paul M, Basson CT, McDermott DA, Lerman BB, Markowitz SM, Ellinor PT, MacRae CA, et al: Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet. 36:1162–1164. 2004. View Article : Google Scholar : PubMed/NCBI
28	Qiu X, Liu W, Hu D, Zhu T, Li C, Li L, Guo C, Liu X, Wang L, Zheng H, et al: Mutations of plakophilin-2 in Chinese with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Am J Cardiol. 103:1439–1444. 2009. View Article : Google Scholar : PubMed/NCBI
29	Wu SL, Wang PN, Hou YS, Zhang XC, Shan ZX, Yu XY and Deng M: Mutation of plakophilin-2 gene in arrhythmogenic right ventricular cardiomyopathy. Chin Med J (Engl). 122:403–407. 2009.PubMed/NCBI
30	Bao J, Wang J, Yao Y, Wang Y, Fan X, Sun K, He DS, Marcus FI, Zhang S, Hui R, et al: Correlation of ventricular arrhythmias with genotype in arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 6:552–556. 2013. View Article : Google Scholar : PubMed/NCBI
31	Joshi-Mukherjee R, Coombs W, Musa H, Oxford E, Taffet S and Delmar M: Characterization of the molecular phenotype of two arrhythmogenic right ventricular cardiomyopathy (arvc)-related plakophilin-2 (pkp2) mutations. Heart Rhythm. 5:1715–1723. 2008. View Article : Google Scholar : PubMed/NCBI
32	Hall C, Li S, Li H, Creason V and Wahl JK III: Arrhythmogenic right ventricular cardiomyopathy plakophilin-2 mutations disrupt desmosome assembly and stability. Cell Commun Adhes. 16:15–27. 2009. View Article : Google Scholar : PubMed/NCBI
33	Kirchner F, Schuetz A, Boldt LH, Martens K, Dittmar G, Haverkamp W, Thierfelder L, Heinemann U and Gerull B: Molecular insights into arrhythmogenic right ventricular cardiomyopathy caused by plakophilin-2 missense mutations. Circ Cardiovasc Genet. 5:400–411. 2012. View Article : Google Scholar : PubMed/NCBI
34	Sato PY, Musa H, Coombs W, Guerrero-Serna G, Patino GA, Taffet SM, Isom LL and Delmar M: Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res. 105:523–526. 2009. View Article : Google Scholar : PubMed/NCBI